N-Myristoyltransferase Inhibition causes Mitochondrial Iron Overload and Parthanatos in TIM17A-dependent Aggressive Lung Carcinoma

By sjmartinez • July 2, 2024

Geroyska S, Mejia I, Chan AA, Navarrete M, Pandey V, Kharpatin S, Noguti J, Wang F, Srole D, Chou TF, Wohlschlegel J, Nemeth E, Damoiseaux R, Shackelford DB, Lee DJ, Diaz B. N-Myristoyltransferase Inhibition causes Mitochondrial Iron Overload and Parthanatos in TIM17A-dependent Aggressive Lung Carcinoma. Cancer Res Commun. 2024 Jul 1. doi: 10.1158/2767-9764.CRC-23-0428. Epub ahead of print. PMID: 38949950.

Tags: Dermatology, Harbor UCLA, Hematology/Oncology, Publications, Pulmonary, Critical Care & Sleep Medicine

Deucravacitinib in plaque psoriasis: Four-year safety and efficacy results from the Phase 3 POETYK PSO-1, PSO-2 and long-term extension trials

Armstrong AW, Lebwohl M, Warren RB, Sofen H, Morita A, Paul C, Papp KA, Colombo MJ, Scotto J, Vaile J, Zhuo J, Vritzali E, Berger[...]

Ethical Considerations in Recommending Patients Avoid Cosmetic Treatments Performed by Non-Physician Providers

Hill RC, Grant-Kels JM, Farshchian M. Ethical Considerations in Recommending Patients Avoid Cosmetic Treatments Performed by Non-Physician Providers. J Am Acad Dermatol. 2025 Feb 24:S0190-9622(25)00356-1.[...]

Validation of DermSat-7 for Assessing Treatment Satisfaction in Patients With Psoriasis

Armstrong AW, Lee K, Yee D, Woodbury M, Zundell M, Zagona-Prizio C, Yousif J, Grant C, Shields A, Chou P, Callis Duffin K, Gottlieb AB,[...]